Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing

View through CrossRef
AbstractN 6-methylation of 2′-O-methyladenosine (Am) in RNA occurs in eukaryotic cells to generate N6,2′-O-dimethyladenosine (m6Am). Identification of the methyltransferase responsible for m6Am catalysis has accelerated studies on the function of m6Am in RNA processing. While m6Am is generally found in the first transcribed nucleotide of mRNAs, the modification is also found internally within U2 snRNA. However, the writer required for catalyzing internal m6Am formation had remained elusive. By sequencing transcriptome-wide RNA methylation at single-base-resolution, we identified human METTL4 as the writer that directly methylates Am at U2 snRNA position 30 into m6Am. We found that METTL4 localizes to the nucleus and its conserved methyltransferase catalytic site is required for U2 snRNA methylation. By sequencing human cells with overexpressed Mettl4, we determined METTL4’s in vivo target RNA motif specificity. In the absence of Mettl4 in human cells, U2 snRNA lacks m6Am thereby affecting a subset of splicing events that exhibit specific features such as 3′ splice-site weakness and an increase in exon inclusion. These findings suggest that METTL4 methylation of U2 snRNA regulates splicing of specific pre-mRNA transcripts.
Title: METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing
Description:
AbstractN 6-methylation of 2′-O-methyladenosine (Am) in RNA occurs in eukaryotic cells to generate N6,2′-O-dimethyladenosine (m6Am).
Identification of the methyltransferase responsible for m6Am catalysis has accelerated studies on the function of m6Am in RNA processing.
While m6Am is generally found in the first transcribed nucleotide of mRNAs, the modification is also found internally within U2 snRNA.
However, the writer required for catalyzing internal m6Am formation had remained elusive.
By sequencing transcriptome-wide RNA methylation at single-base-resolution, we identified human METTL4 as the writer that directly methylates Am at U2 snRNA position 30 into m6Am.
We found that METTL4 localizes to the nucleus and its conserved methyltransferase catalytic site is required for U2 snRNA methylation.
By sequencing human cells with overexpressed Mettl4, we determined METTL4’s in vivo target RNA motif specificity.
In the absence of Mettl4 in human cells, U2 snRNA lacks m6Am thereby affecting a subset of splicing events that exhibit specific features such as 3′ splice-site weakness and an increase in exon inclusion.
These findings suggest that METTL4 methylation of U2 snRNA regulates splicing of specific pre-mRNA transcripts.

Related Results

METTL4 catalyzes m6Am methylation inU2 snRNAto regulate pre-mRNA splicing
METTL4 catalyzes m6Am methylation inU2 snRNAto regulate pre-mRNA splicing
AbstractN6-methylation of 2’-O-methyladenosine (Am) in RNA occurs in eukaryotic cells to generateN6,2’-O-dimethyladenosine (m6Am). Identification of the methyltransferase responsib...
Decoding m6Am by simultaneous transcription-start mapping and methylation quantification
Decoding m6Am by simultaneous transcription-start mapping and methylation quantification
Abstract N6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiol...
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract Background: DNA methylation in promoter regions leads to transcriptional silencing, such as of tumor suppressor genes in cancer. However, the functions of D...
Genome-wide survey of allele-specific splicing in humans
Genome-wide survey of allele-specific splicing in humans
Abstract Background Accurate mRNA splicing depends on multiple regulatory signals encoded in the transcribed RNA sequence. Many examples of mutat...
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract Alternative mRNA splicing is dysregulated in many cancers including lung adenocarcinoma. These aberrant splicing events can sometimes be explained by mutati...
m6Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
m6Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
AbstractPCIF1 (phosphorylated CTD interacting factor 1) is the first reported RNA N6,2′-O-dimethyladenosine (m6Am) methyltransferase. However, the pathological significance of PCIF...
Tissue renin angiotensin system in IgA nephropathy
Tissue renin angiotensin system in IgA nephropathy
The inhibition of angiotensin II (AngII) by use of angiotensin converting enzyme (ACE) inhibitor or AngII receptor blocker is effective for prevention of the progression of renal d...
Crystal structures of U6 snRNA-specific terminal uridylyltransferase
Crystal structures of U6 snRNA-specific terminal uridylyltransferase
AbstractThe terminal uridylyltransferase, TUT1, builds or repairs the 3′-oligo-uridylylated tail of U6 snRNA. The 3′-oligo-uridylylated tail is the Lsm-binding site for U4/U6 di-sn...

Back to Top